- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01542983
Prophylactic Treatment of Sleep/Fatigue Before and During Chemotherapy
Feasibility of Prophylactic Treatment of Sleep/Fatigue Before and During Chemotherapy for Breast Cancer
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Women with breast cancer (BC) report poor sleep and fatigue, occasionally before, and often during chemotherapy. These symptoms often last for months and even years after the end of cancer treatment, significantly burdening the patients' quality of life (QOL), decreasing their overall functional level and potentially hindering the patients' re-integration into productive society. Improvement in the domains of sleep and fatigue might result in overall improvement in QOL. The investigators have shown that women with breast cancer with a symptom cluster of poor sleep, fatigue and depressive symptoms before chemotherapy are more likely to manifest an increase in severity of these symptoms and decreased QOL during chemotherapy.
A randomized controlled treatment study is now warranted to examine whether concurrent treatment of sleep and fatigue, begun before chemotherapy and continuing during chemotherapy, will prevent deterioration of sleep and fatigue during chemotherapy, and since poor sleep and fatigue are related to mood, whether these improvements will then lead to improvements in the symptom cluster of sleep/fatigue/mood as well as in QOL and cognitive functioning during chemotherapy. Before a full study can be initiated, the investigators propose a pilot study to examine the feasibility of conducting this type of treatment study.
The main aims of this pilot study are:
AIM 1: To examine whether the investigators can recruit 20 women with newly diagnosed breast cancer, before they begin chemotherapy, whether or not they are currently experiencing poor sleep and fatigue, into a treatment study that aims at preventing or mitigating poor sleep, fatigue, depressive symptoms during chemotherapy.
AIM 2: To examine whether women recruited into this study will be compliant with the sleep/fatigue treatment for a full four cycles of chemotherapy.
The results of this study plus the preliminary scientific data collected will be used as pilot data for an RO1 with the following aims: Aim 1 - Symptom cluster of sleep/fatigue/mood: To examine the effects of concurrent treatment of poor sleep and fatigue, begun before the start of chemotherapy and continuing during chemotherapy, on the symptom cluster of sleep/fatigue/mood during chemotherapy (hypothesis 1: Women with newly diagnosed breast cancer treated concurrently with Brief Behavioral Treatment of Insomnia (BBTI) and morning bright light therapy (BLT) before the start of and during chemotherapy, will experience fewer symptoms within the cluster of poor sleep, fatigue, depressive symptoms during chemotherapy than women in the information-only control group). Aim 2 - QOL and Cognition: To examine the effects of concurrent treatment of poor sleep and fatigue, begun before the start of chemotherapy and continuing during chemotherapy, on cognitive functioning (as measured with a targeted neuropsychological test battery) and QOL during chemotherapy (hypothesis 2: Women with newly diagnosed breast cancer treated concurrently with BBTI and morning BLT before the start of and during chemotherapy, will experience less deterioration in cognitive functioning and better QOL during chemotherapy than women in the information-only control group).
The innovation of larger application will be that the study intervention is a dual modality intervention (BBTI and BWL), not previously studied in combination and that it ultimately seeks to shift the clinical practice paradigm from a reactive to a proactive, preventive cancer care model.
The investigators are proposing a clinical trial to treat all patients, whether or not they are currently experiencing problems with sleep and fatigue, with the goal of preventing or ameliorating the severity of symptoms during chemotherapy, and compare them to an information-only control group (IC) (see Fig. 1). This pilot study will help us determine the feasibility of such a study.
Studietyp
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
California
-
La Jolla, California, Förenta staterna, 92093
- Moores UCSD Cancer Center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- stage I-III breast cancer referred for chemotherapy
- English speaking
- over age 18
Exclusion Criteria:
- Pregnancy (by self-report; poor sleep and fatigue are sometimes associated with pregnancy);
- Metastatic or unresectable breast cancer;
- Patients who have been told they have sleep apnea, restless legs or periodic limb movements in sleep whether or not they are currently treated;
- History of bipolar disorder or history of mania;
- Current diagnosis of psychotic disorder;
- Blindness or other physical or psychological impairments which would limit participation;
- Shift workers;
- Women with infants who still disturb the mother's sleep.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Treatment-as-usual
Treatment as usual for fatigue and insomnia
|
Standard treatment for fatigue and insomnia
|
Aktiv komparator: Behavioral treatment
Brief behavioral treatment for insomnia and bright light Light and BBTI combined treatment for insomnia and fatigue
|
daily bright light exposure; 2 sessions for insomnia
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
fatigue
Tidsram: 12 weeks
|
Change in fatigue from pre-chemotherapy to post cycle 4 chemotherapy
|
12 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
sleep
Tidsram: 12 weeks
|
Changes in sleep and sleep quality will be assessed from pre-chemotherapy to post-cycle 4 chemotherapy
|
12 weeks
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Sonia Ancoli-Israel, PhD, UCSD
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 120108
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Stage, Breast Cancer
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital och andra samarbetspartnersAvslutadDen kliniska tillämpningsguiden för Conebeam Breast CTKina
-
ETOP IBCSG Partners FoundationAvslutadBreast Cancer Invasive NosItalien
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.AAvslutadBreast Cancer Invasive NosSpanien
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional...OkändBRCA1-mutation | Breast Cancer Invasive NosPolen
-
University Health Network, TorontoAvslutadBreast Cancer Invasive Nos | Primär invasiv bröstcancerKanada
-
Novartis PharmaceuticalsAvslutadMetastaserad bröstcancer (MBC) | Locally Advance Breast Cancer (LABC)Storbritannien, Spanien
-
McMaster UniversityCanadian Breast Cancer FoundationAvslutadBreast Cancer Invasive Nos | Steg 0 BröstkarcinomKanada
Kliniska prövningar på treatment as usual
-
Duke UniversityNational Institute of Nursing Research (NINR); Palliative Care Research...Avslutad
-
Wake Forest University Health SciencesDuke University; University of RochesterAvslutadSjälvmord | Föräldraskap | Självförmåga | Ångest; ModerligFörenta staterna
-
Hôpital le VinatierNantes University Hospital; Centre Hospitalier Henri Laborit; University... och andra samarbetspartnersAvslutadKronisk schizofreniFrankrike
-
Brown UniversityNational Institute of Mental Health (NIMH)RekryteringHIV/AIDSFörenta staterna
-
The University of Texas Health Science Center at...AvslutadKronisk smärtaFörenta staterna
-
Ioannis A. MalogiannisNational and Kapodistrian University of Athens; Attikon Hospital; University... och andra samarbetspartnersRekrytering
-
International Rescue CommitteeJohns Hopkins University; World Health OrganizationAvslutad
-
Case Western Reserve UniversityAvslutadBipolär sjukdomFörenta staterna
-
University of MichiganNational Institute of Mental Health (NIMH)RekryteringPosttraumatisk stressyndromFörenta staterna
-
Massachusetts General HospitalNational Institute on Drug Abuse (NIDA); University of Houston; Southern...AvslutadHIV | Nikotinberoende | Symtom på ångestFörenta staterna